Results 11 to 20 of about 38,260 (253)

Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder [PDF]

Frontiers in Psychiatry, 2021
Daniel Feingold, Eva Hoch, Eva Hoch, Aviv Weinstein, Wayne Hall   +4 more
doaj   +5 more sources

Cannabis use and cannabis use disorder

Nature Reviews Disease Primers, 2021
Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global ...
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, Eva Hoch, Alan J. Budney, Wayne D. Hall   +5 more
  +9 more sources

Pain, Cannabis Species, and Cannabis Use Disorders [PDF]

Journal of Studies on Alcohol and Drugs, 2016
The purpose of this study was to examine whether individuals who used medical cannabis for chronic pain were at increased risk for cannabis use problems compared with individuals who used medical cannabis for other reasons (e.g., anxiety, insomnia, and muscle spasms).
Nicole L, Cohen, Adrienne J, Heinz, Mark, Ilgen, Marcel O, Bonn-Miller   +3 more
openaire   +2 more sources

The Use of Cannabis for Headache Disorders [PDF]

Cannabis and Cannabinoid Research, 2017
Headache disorders are common, debilitating, and, in many cases, inadequately managed by existing treatments. Although clinical trials of cannabis for neuropathic pain have shown promising results, there has been limited research on its use, specifically for headache disorders.
Lochte, Bryson, Beletsky, Alexander, Samuel, Nebiyou, Grant, Igor   +3 more
openaire   +4 more sources

Interventions for cannabis use disorder

Current Opinion in Psychology, 2021
How to treat adults and adolescents with a Cannabis Use Disorder is a burgeoning research area. This article reviews the empirical literature pertaining to several psychosocial approaches (cognitive-behavior therapy, motivational enhancement, and contingency management), all of which are associated with favorable outcomes.
Ken C. Winters, Joel Mader, Alan J. Budney, Catherine Stanger, Ashley A. Knapp, Denise D. Walker   +5 more
openaire   +3 more sources

Genetic basis of cannabis use: a systematic review

BMC Medical Genomics, 2021
Background With the increase in cannabis use rates, cannabis use disorder is being reported as one of the most common drug use disorders globally.
Alannah Hillmer, Caroul Chawar, Stephanie Sanger, Alessia D’Elia, Mehreen Butt, Raveena Kapoor, Flavio Kapczinski, Lehana Thabane, Zainab Samaan   +8 more
doaj   +1 more source

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder

Translational Psychiatry, 2023
Cannabidiol (CBD) has shown promise in treating psychiatric disorders, including cannabis use disorder – a major public health burden with no approved pharmacotherapies. However, the mechanisms through which CBD acts are poorly understood.
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J. Morgan, Ali Mofeez, H. Valerie Curran, Tom P. Freeman   +8 more
doaj   +1 more source

Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis

Journal of Medical Internet Research, 2022
BackgroundPrevalence rates for lifetime cannabis use and cannabis use disorder are much higher in people with attention deficit/hyperactivity disorder than in those without.
Joachim Ahlers, Christian Baumgartner, Mareike Augsburger, Andreas Wenger, Doris Malischnig, Nikolaos Boumparis, Thomas Berger, Lars Stark, David D Ebert, Severin Haug, Michael P Schaub   +10 more
doaj   +1 more source

Association of Dopamine Transporter Gene (DAT1) 40 bp 3′ UTR VNTR Polymorphism (rs28363170) and Cannabis Use Disorder

Substance Abuse: Research and Treatment, 2023
Introduction: Cannabis remains the most widely used illicit drug among Nigerians, often associated with psychiatric disorders. Since genetic predisposition has been implicated in substance use disorders, we, therefore, aimed at finding out the ...
Holiness SA Olasore, Akinniyi A Osuntoki, Olubunmi A Magbagbeola, Abdur-Rasheed B Awesu, Anthony A Olashore   +4 more
doaj   +1 more source

An exploratory study of cannabis use pattern and treatment seeking in patients attending an addiction treatment facility

Indian Journal of Psychiatry, 2020
Background and Aims: Although cannabis is the most common illicit substance of use in India, it is often not the presenting complaint of patients with substance use disorders.
Siddharth Sarkar, Arpit Parmar, Amit Singh   +2 more
doaj   +1 more source